http://www.angirx.com/blog/rheumatic-heart-disease-images/
rheumatic heart disease images
Winning the war against rheumatoid arthritis
Rheumatoid arthritis is a condition that forces half of patients with disability in the workforce five to ten years € | and reduces life expectancy by up to 18 years. Rheumatoid arthritis affects approximately one percent of the world € ™ s adult population, mostly women between the ages of 30 and 50.
The good news is that much progress were made in the last decade in the identification of patients before treatment and a more aggressive disease. Patients with RA, if treated properly, can lead a relatively normal life. This is in marked contrast with the wheelchair bound existence common as recently only 20 years!
The experts consider that early rheumatoid arthritis to be a medical emergency with mortality and morbidity even as diabetes, asthma, heart disease and the lives of other hazardous conditions.
Rheumatoid arthritis attacks the joints and symmetrical (both sides of the body affected equally) with the most common areas are the hands, wrists, ankles, knees and feet. Besides Patients with inflammation and pain with rheumatoid arthritis often have a profound fatigue and stiffness.
Rheumatoid arthritis is a disease autoimmune disease that attacks not only joints but the internal organs such as blood vessels, lungs, heart and eyes. Patients with RA have increased risk of heart attack, stroke, and lymphoma.
For many other types of arthritis such as gout, lupus, rheumatoid arthritis and osteoarthritis may appear a careful diagnostic approach is necessary.
Laboratory testing has its pitfalls. Factor arthritis, Blood tests were positive about 80 percent of people with RA may also be useful in other diseases. Add to this the fact that 20 percent of patients with rheumatoid arthritis is rheumatoid factor negative, then it becomes clear diagnosis should not depend on the results blood tests alone.
The imaging procedures can also be misleading. Conventional radiographs often miss the erosions found the disease childhood. Technology more recent image as magnetic resonance imaging (MRI) and ultrasound are much more sensitive.
After diagnosis hope there is more than a day patient. In the past, not anti-inflammatory drugs (NSAIDs) are regarded as the stone mainstay of therapy. This is not true.
Modification of the drug in the fight against rheumatic diseases (DMARDs) are used before. Among treatments background currently used are methotrexate, leflunomide (Arava), azathioprine (Imuran) sulfasalazine (Azulfidine), cyclosporine and hydroxychloroquine (Plaquenil). These drugs attack the immune cells responsible for inflammation chronic. While DMARDs in combination is effective, relatively nonspecific. Often, combinations of DMARDs are necessary.
Biological Response Modifiers (BRMS) can attack the disease, more specifically, FAME. Rheumatoid arthritis is a disease that depends on the signaling that occurs between immune cells. Signaling is done through the use of special chemical messengers called cytokines. Action in both the BRMS cytokines (chemical messengers) and allows a cellular level the disease to be better controlled and, in some instances put into remission.
Modifiers of the biological response, which include drugs that inhibit tumor necrosis factor (TNF), appear be particularly effective.
Tumor necrosis factor is a protein that is produced by immune cells. TNF is the main culprit responsible inflammation, causing damage. By blocking the effects of TNF, better control of RA can be achieved.
Three anti-TNF drugs are currently available: etanercept (Enbrel), adalimumab (Humira) and infliximab (Remicade). Another biologic drug, anakinra (Kineret ®) blocks interleukin, a cytokine different.
These drugs allow patients to control their disease so that most are able to enjoy a normal life of work and leisure.
Second-line biological agents such as Rituxan and Orencia rheumatologists can treat patients who have no medicines anti-TNF.
On the horizon are other biologic drugs work in different parts of the immune system and different cytokines on how to better control and more specific disease. Since rheumatoid arthritis is a disease with many different cytokine and cellular mechanisms responsible for damage, attacking the disease at different points is defined. In May the future it will be possible to identify patients through specific tissue signals (called œbiomarkersâ € €). These biomarkers allow physicians to type patients and give patients a specific treatment will work best for them. Once achieved, the possibility of a cure becomes a reality.
All, however, begins with an accurate diagnosis early. If the damage to the probability of falling dramatically discount!
About the Author
Author writes articles on different topics. To know more, visit:
acne exposed system treatment,www.arthritis-treatment-and-relief.com
[mage lang="en|es|fr|en" source="answers"]rheumatic heart disease images[/mage]
[affmage source="amazon" results="3"]rheumatic heart disease images[/affmage]
[affmage source="clickbank" results="2"]rheumatic heart disease images[/affmage]
[affmage source="cj" results="1"]rheumatic heart disease images[/affmage]